Heart palpitations; Almost paralyzed; Excessive sweating; My blood pressure started being very low now extremely high; TH3 liver elevated; Heart disorder; Lungs disorder; Kidney disorder; Liver disorder; Eyes disorder; Blood clotting; severe Headaches; Blurry vision; Whole body on fire/ face and spine on fire; No taste; Feels like something is attacking my insides my eardrums; No smell; Swallowing stomach; 1st dose Shingrix received on 11-Jan-2022 and 2nd dose on 8-Aug-2022; This serious case was reported by a consumer via other manufacturer and described the occurrence of heart disorder in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu unspecified (Flu vaccine) for prophylaxis and TOZINAMERAN (PFIZER COVID VACCINE) (batch number EL0142) for prophylaxis.   Previously administered products included Z Pack with an associated reaction of hypersensitivity, topiramate with an associated reaction of hypersensitivity, metformin with an associated reaction of hypersensitivity, oxycodone with an associated reaction of hypersensitivity and Shingrix (1st dose received on 11th January 2022). Concurrent medical conditions included migraine, fibromyalgia, depression and heart disease, unspecified. Concomitant products included acetylsalicylic acid (Aspirin), metoprolol, atorvastatin, hydrocodone and sertraline hydrochloride (Sertra).   On 08-AUG-2022, the patient received the 2nd dose of Shingrix, the 1st dose of Flu vaccine and the 4th dose of PFIZER COVID VACCINE (right arm). On 08-AUG-2022, an unknown time after receiving Shingrix and not applicable after receiving Flu vaccine, the patient experienced drug dose administration interval too long (Verbatim: 1st dose Shingrix received on 11-Jan-2022 and 2nd dose on 8-Aug-2022). On 08-AUG-2022 16:45, the patient experienced heart disorder (Verbatim: Heart disorder) (serious criteria life threatening), lung disorder (Verbatim: Lungs disorder) (serious criteria life threatening), renal disorder (Verbatim: Kidney disorder) (serious criteria life threatening), liver disorder (Verbatim: Liver disorder) (serious criteria life threatening), eye disorder (Verbatim: Eyes disorder) (serious criteria life threatening), clot blood (Verbatim: Blood clotting) (serious criteria GSK medically significant and life threatening), headache (Verbatim: severe Headaches) (serious criteria life threatening), blurred vision (Verbatim: Blurry vision) (serious criteria life threatening), burning sensation (Verbatim: Whole body on fire/ face and spine on fire) (serious criteria life threatening), taste absent (Verbatim: No taste) (serious criteria life threatening), ear discomfort (Verbatim: Feels like something is attacking my insides my eardrums) (serious criteria life threatening), anosmia (Verbatim: No smell) (serious criteria life threatening) and stomach discomfort (Verbatim: Swallowing stomach) (serious criteria life threatening). On an unknown date, the patient experienced palpitation (Verbatim: Heart palpitations) (serious criteria life threatening), paralysis (Verbatim: Almost paralyzed) (serious criteria GSK medically significant and life threatening), excess sweating (Verbatim: Excessive sweating) (serious criteria life threatening), blood pressure fluctuation (Verbatim: My blood pressure started being very low now extremely high) (serious criteria life threatening) and tri-iodothyronine increased (Verbatim: TH3 liver elevated) (serious criteria life threatening).  The outcome of the heart disorder, lung disorder, renal disorder, liver disorder, eye disorder, clot blood, headache, blurred vision, burning sensation, taste absent, ear discomfort, anosmia and stomach discomfort were not resolved and the outcome of the palpitation, paralysis, excess sweating, blood pressure fluctuation and tri-iodothyronine increased were not reported and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the heart disorder, lung disorder, renal disorder, liver disorder, eye disorder, clot blood, headache, blurred vision, burning sensation, taste absent, ear discomfort, anosmia, stomach discomfort, palpitation, paralysis, excess sweating, blood pressure fluctuation and tri-iodothyronine increased to be related to Shingrix and Flu vaccine.     It was unknown if the company considered the heart disorder, lung disorder, renal disorder, liver disorder, eye disorder, clot blood, headache, blurred vision, burning sensation, taste absent, ear discomfort, anosmia, stomach discomfort, palpitation, paralysis, excess sweating, blood pressure fluctuation and tri-iodothyronine increased to be related to Shingrix and Flu vaccine.   Additional Information: GSK Receipt Date: 29-AUG-2023 The patient received Aspirin, metoprolol, atorvastatin, hydrocodone and sertra within 2 weeks of vaccination. The most recent COVID-19 vaccine was administered at pharmacy or drug store. The reporter reported that the patient immunity system was being attacked. The patient reported that no one was doing anything. he or she had been to the emergency room about six times. And stated that send him or her right back to the home with no type of treatment.  The patient reported that on 8th August 2023 made a year that he or she had been suffering.  The patient reported that after a while he or she thought he or she not going to be living and no one was listened to him or her. On 08-AUG-2022 16:45, less than a day after received Pfizer covid vaccine patient experienced heart disorder, lung disorder, renal disorder, liver disorder, eye disorder, clot blood, headache, blurred vision, burning sensation, taste absent, ear discomfort, anosmia and stomach discomfort. On an unknown date, unknown time after receiving Pfizer covid vaccine the patient experienced palpitation, paralysis, excess sweating, blood pressure fluctuation and tri-iodothyronine increased. It was unknown if the reporter considered the adverse events to be related to Pfizer covid vaccine. Follow-up would not possible as no contact details were available.